presenc
consist
express
gene
encod
human
papillomaviru
hpv
protein
great
major
cervic
tumour
present
opportun
immunotherapeut
approach
control
diseas
report
describ
construct
characteris
recombin
vaccinia
viru
design
express
modtfi
form
protein
virus
commonli
associ
cervic
cancer
recombin
viru
design
tahpv
base
wyeth
vaccin
strain
vaccinia
shown
express
desir
gene
product
studi
mice
indic
recombin
viru
less
neurovirul
parent
viru
capabl
induc
hpvspectftc
ctl
respons
preclin
evalu
provid
basi
initi
human
trial
cervic
cancer
patient
copyright
elsevi
scienc
ltd
past
decad
becom
increasingli
clear
cervic
cancer
close
link
infect
certain
type
human
papillomaviru
hpv
conclus
base
sever
line
evid
includ
observ
cervic
tumour
contain
hpv
dna
differ
type
hpv
describ
limit
number
associ
tumour
oncogen
hpv
commonli
found
occur
tumour
occur
number
hpv
also
found
albeit
rare
includ
hpv
infect
oncogen
virus
howev
necessarili
lead
tumour
develop
substanti
proport
healthi
women
show
evid
infect
vast
major
infect
lead
malign
diseas
appear
rather
presenc
virus
genit
tract
may
long
period
time
predispos
develop
cervic
cancer
provid
one
element
multistag
process
tumourigenesi
cervic
tumour
cell
gener
contain
complet
hpv
genom
consist
featur
retent
express
portion
viru
genom
encod
two
earli
viru
protein
increas
bodi
evid
indic
express
protein
contribut
transform
process
vitro
studi
shown
gene
oncogen
hpv
immortalis
cell
protein
known
interact
inhibit
activ
cellular
protein
control
cell
divis
bind
cellular
retinoblastoma
rb
bind
cellular
furthermor
recent
studi
suggest
continu
express
within
tumour
cell
requir
maintain
transform
state
regardless
role
transform
howev
presenc
protein
cervic
tumour
cell
offer
unusu
clear
cut
opportun
cancer
immunotherapi
sinc
repres
genuin
tumourspecif
antigen
could
act
target
destruct
tumour
cell
without
damag
healthi
host
cell
sinc
protein
intracellular
immun
effector
mechan
like
effect
cervic
tumour
cell
cytotox
lymphocyt
ctl
ctl
destroy
cell
express
foreign
antigen
recognit
peptid
fragment
gener
within
cell
transport
cell
surfac
present
major
histocompat
complex
mhc
class
antigen
number
studi
indic
ctl
potenti
power
agent
tumour
cell
destruct
furthermor
experiment
data
anim
model
indic
hpv
protein
act
target
ctlmediat
tumour
cell
induct
antigenspecif
ctl
respons
gener
requir
target
antigen
produc
insid
host
cell
order
proper
antigen
process
mhc
class
imedi
present
occur
accomplish
use
recombin
viru
vector
carri
gene
target
antigen
report
describ
design
construct
characteris
recombin
vaccinia
viru
express
protein
hpv
type
specif
purpos
induc
benefici
immun
respons
human
result
earli
stage
clinic
studi
viru
present
separ
report
borysiewicz
et
al
submit
public
includ
complet
code
sequenc
clone
genom
polymeras
chain
reaction
pcr
plasmid
vector
gener
facilit
clone
primer
pcr
chosen
introduc
ncoi
restrict
site
around
start
codon
posit
gene
cc
atg
g
smai
site
immedi
downstream
equival
strategi
use
introduc
restrict
site
around
start
codon
posit
clone
code
sequenc
yield
plasmid
plasmid
modifi
standard
site
direct
mutagenesi
method
creat
fuse
code
sequenc
b
introduc
mutat
rb
bind
site
c
elimin
potenti
termin
signal
earli
vaccinia
viru
transcript
code
sequenc
figur
figur
manipul
gener
plasmid
fuse
unmodifi
code
sequenc
fuse
modifi
code
sequenc
fuse
unmodifi
code
sequenc
fuse
modifi
code
sequenc
plasmid
modifi
site
direct
mutagenesi
remov
code
sequenc
place
gene
adjac
phage
rna
polymeras
promot
gener
plasmid
pimer
pimer
pimer
pimer
respect
plasmid
ad
coupl
vitro
transcriptiontransl
system
tnt
amersham
intern
protein
product
test
rb
figur
amodif
rb
bind
site
gene
nucleotid
chang
shown
underlin
made
oligonucleotidemedi
sitedirect
mutagenesi
confirm
nucleotid
sequenc
emodifi
unmodifi
form
produc
label
rabbit
reticulolys
system
product
reaction
immunoprecipit
either
antirb
origin
reaction
contain
radiolabel
lane
modifi
lane
lane
modifi
lane
bind
brief
unlabel
rb
protein
produc
vitro
translat
plasmid
pcrb
mix
radiolabel
vitro
translat
hpv
protein
mixtur
immunoprecipit
use
antibodi
direct
rb
monoclon
antibodi
ifsa
gift
professor
david
lane
dunde
univers
hpv
polyclon
gift
dr
j
morri
ludwig
institut
cancer
research
london
hpv
cocktail
monoclon
antibodi
dr
r
tindl
lion
human
immunolog
laboratori
brisban
precipit
analys
sd
polyacrylamid
gel
electrophoresi
page
autoradiographi
assess
use
assay
base
cotransform
rat
embryo
fibroblast
activ
ra
code
sequenc
correspond
fuse
gene
without
rb
bind
site
mutat
excis
plasmid
respect
use
bamhi
fragment
clone
two
mammalian
cell
express
vector
allow
express
heterolog
gene
control
promot
moloney
leukaemia
ltr
promot
control
plasmid
contain
wild
type
code
sequenc
describ
previous
transform
assay
contain
test
plasmid
pug
express
plasmid
contain
harvey
ra
oncogen
pej
pug
plasmid
surviv
coloni
count
week
cultur
plasmid
construct
contain
lkb
sequenc
span
symmetr
chosen
insert
site
within
vaccinia
viru
genom
figur
prepar
directli
vaccinia
viru
dna
pcr
also
contain
guanin
phosphoribosyl
transferas
gpt
gene
control
vaccinia
viru
gene
origin
replic
phage
fl
snabi
site
introduc
chosen
insert
site
within
vaccinia
specif
sequenc
final
recombin
vector
figur
insert
code
sequenc
vaccinia
genom
deriv
insert
snabi
site
dna
cassett
follow
element
fuse
modifi
sequenc
control
vaccinia
specif
headtohead
orient
fuse
modifi
sequenc
control
vaccinia
specif
promot
twostag
transient
domin
select
procedur
use
recombin
hpv
gene
vaccinia
genom
figur
viru
isol
gener
procedur
screen
presenc
desir
introduct
hpv
code
sequenc
vaccinia
viru
genom
plasmid
transfect
vero
cell
cell
coinfect
parent
vaccinia
viru
progeni
viru
contain
complet
copi
plasmid
isol
mycophenol
acid
select
passag
absenc
select
give
rise
viru
tahpv
contain
hpv
gene
express
cassett
sibl
viru
exactli
equival
except
contain
hpv
insert
hpv
insert
pcr
analysi
singl
recombin
viru
select
characteris
vaccinia
virusinfect
vero
cell
harvest
resuspend
pb
viru
releas
cycl
freezethaw
nuclei
remov
centrifug
min
viru
recov
result
supernat
centrifug
microfug
min
pellet
resuspend
incub
buffer
contain
proteinas
k
extract
phenolchloroform
isoamyl
alcohol
dna
recov
ethanol
precipit
initi
genom
characteris
carri
pcr
analysi
subsequ
nucleotid
sequenc
insert
determin
cycl
sequenc
use
commerci
avail
kit
promega
inc
set
oligonucleotid
primer
design
cover
hpv
code
sequenc
respect
promot
therapeut
vaccin
cervic
cancer
eg
boursnel
et
al
cell
x
infect
wyeth
strain
vaccinia
viru
multipl
pfucel
incub
infect
cell
harvest
recov
centrifug
resuspend
sdspage
sampl
buffer
lysat
subject
page
gel
content
transfer
nitrocellulos
electroblot
blot
wash
phosphatebuff
salin
pb
contain
milk
protein
rins
pb
incub
appropri
primari
antibodi
dilut
pb
contain
tween
pbst
bovin
serum
albumin
bsa
lh
room
temperatur
sequenc
detect
respect
use
antibodi
camvir
gift
dr
stanley
depart
patholog
univers
cambridg
antibodi
protein
use
neg
control
blot
wash
pbst
incub
h
goat
antimous
horseradish
peroxidaseconjug
antibodi
pbst
contain
sheep
serum
final
wash
pbst
label
band
reveal
stain
diaminobenziden
tetrahydrochlorid
dabh
radiolabel
protein
molecular
weight
marker
detect
autoradiographi
nitrocellulos
sheet
intranas
inocul
group
mice
infect
intranas
pfu
either
tahpv
parent
wyeth
viru
six
anim
group
sacrif
day
day
day
lung
anim
remov
analysi
storag
amount
viru
present
assess
standard
plaqu
assay
intracrani
inocul
group
anim
inject
intracrani
three
differ
dose
tahpv
pfu
wyeth
parent
viru
group
anim
inocul
pb
serv
neg
control
surviv
anim
monitor
twice
daili
day
femal
mice
age
week
immunis
time
intraperiton
x
pfu
either
tahpv
parent
strain
wyeth
vaccinia
viru
recombin
vaccinia
viru
express
sequenc
gift
dr
sn
stacey
paterson
institut
cancer
research
manchest
uk
modif
sequenc
wild
type
n
terminu
metglyserprogli
place
wild
type
methisgli
pb
immunis
mice
also
use
control
nine
day
final
immunis
mice
kill
singl
cell
suspens
prepar
spleen
cell
cultur
x
lo
ml
presenc
fm
synthet
peptid
correspond
residu
r
h
n
v
f
repres
epitop
recognis
specif
restrict
ctl
cultur
restimul
weekli
harvest
recultur
cell
x
well
presenc
x
syngen
spleen
cell
mitomycin
c
treat
pm
peptid
supernat
con
activ
rat
splenocyt
sourc
loiuml
sigma
cultur
maintain
supplement
iml
penicillin
streptomycin
mm
lglutamin
pm
mercaptoethanol
heat
inactiv
foetal
calf
serum
target
cell
either
rma
rauscher
viru
transform
lymphoma
cell
lymphoma
vaccinia
viru
infect
target
cell
prepar
infect
overnight
pfucel
cell
label
cell
min
wash
appropri
puls
restrict
ctl
epitop
influenza
viru
nucleoprotein
h
wash
cell
resuspend
x
cell
suspens
ad
per
well
round
bottom
well
plate
six
day
restimul
cell
peptid
stimul
cultur
harvest
threefold
dilut
prepar
ad
per
well
give
rang
effector
target
e
cell
ratio
test
triplic
control
well
also
prepar
contain
target
cell
plu
medium
alon
spontan
chromium
releas
target
cell
plu
triton
maximum
releas
plate
centrifug
rpm
min
cell
incub
h
end
period
ul
supernat
harvest
count
wallac
microbeta
plu
liquid
scintil
counter
specif
lysi
determin
standard
formula
specif
lysi
sampl
releas
cpm
spontan
releas
cpm
maximum
releas
cpm
spontan
releas
cpm
vaccinia
viru
chosen
vector
deliveri
hpv
gene
sequenc
number
reason
first
vaccinia
viru
use
massiv
scale
vaccin
smallpox
henc
great
deal
inform
avail
safeti
human
complic
occur
result
rare
occur
mainli
children
inadvertantli
spread
viru
eye
thu
treatment
cervic
tumour
prognosi
poor
potenti
benefit
approach
clearli
outweigh
risk
genom
vaccinia
viru
readili
manipul
incorpor
addit
infect
recombin
vaccinia
virus
express
heterolog
antigen
induc
varieti
immun
respons
includ
ctl
experiment
anim
final
recombin
vaccinia
virus
express
varieti
tumourassoci
antigen
includ
encod
papillomavirus
use
success
provid
protect
tumour
growth
anim
model
vaccinia
viru
also
provid
certain
particular
advantag
deliveri
hpv
gene
gene
believ
contribut
oncogen
process
abl
immortalis
cell
cultur
import
therefor
consid
likelihood
vaccin
recombin
viru
could
lead
long
term
express
could
result
cell
transform
sinc
vaccinia
lytic
viru
replic
cell
cytoplasm
establish
state
persist
latenc
possibl
cell
infect
recombin
express
could
surviv
becom
tumorigen
extrem
small
furthermor
express
heterolog
dna
vaccinia
genom
depend
upon
specialist
vaccinia
promot
differ
substanti
normal
mammalian
cell
promot
reli
vacciniaencod
transcript
compon
therefor
highli
unlik
dna
releas
recombin
vaccinia
viru
infect
cell
could
taken
healthi
cell
lead
long
term
gene
express
also
remot
chose
wyeth
vaccin
strain
vaccinia
construct
hpvrecombin
viru
basi
among
variou
strain
use
smallpox
vaccin
campaign
associ
lowest
level
complic
consid
protein
valid
target
rais
antitumour
respons
furthermor
sinc
major
tumour
contain
dna
either
elect
includ
code
sequenc
viru
type
simplifi
problem
express
four
differ
heterolog
code
sequenc
within
singl
recombin
vaccinia
viru
code
sequenc
fuse
togeth
sitedirect
mutagenesi
creat
singl
open
read
frame
viru
type
sinc
gene
lie
immedi
downstream
genom
achiev
replac
termin
triplet
four
nucleotid
sequenc
remov
stop
codon
align
two
read
frame
creat
simpl
fusion
two
code
sequenc
link
amino
acid
sequenc
glyil
sequenc
glyileleus
case
sequenc
figur
note
open
read
frame
hpvl
contain
sequenc
tttttattctagaatagag
posit
start
sequenc
contain
motif
tttttnt
could
act
termin
signal
vaccinia
also
region
particularli
close
similar
code
sequenc
therefor
modifi
region
sitedirect
mutagenesi
avoid
potenti
improp
gene
express
recombin
two
set
homolog
sequenc
within
recombin
viru
genom
figur
z
c
done
without
alter
amino
acid
code
sequenc
although
potenti
risk
oncogenesi
follow
infect
recombin
vaccinia
express
sequenc
undoubtedli
extrem
low
creat
margin
safeti
alter
sequenc
reduc
capac
cell
immortalis
achiev
site
direct
mutagenesi
code
sequenc
manner
predict
abolish
bind
cellular
rb
protein
figur
thu
codon
known
crucial
rb
bind
conserv
number
differ
rb
bind
alter
glycin
codon
likewis
equival
codon
alter
glycin
codon
confirm
chang
introduc
code
sequenc
inde
abolish
rb
bind
use
previous
publish
wild
type
modifi
code
sequenc
transcrib
translat
vitro
presenc
radiolabel
amino
acid
extract
mix
unlabel
vitro
translat
cellular
rb
protein
bind
assess
immunoprecipit
radiolabel
hpv
protein
use
antirb
monoclon
antibodi
figur
b
presenc
band
correspond
wild
type
protein
lane
respect
confirm
capac
bind
rb
bind
could
detect
howev
use
protein
carri
rb
bind
site
modif
lane
experi
assess
capac
alter
code
sequenc
mediat
transform
primari
rat
embryo
fibroblast
use
assay
base
cotransform
activ
ra
oncogen
modifi
unmodifi
form
sequenc
clone
plasmid
adjac
molv
ltr
promot
cotransform
capac
compar
tabl
transform
wild
type
driven
either
promot
produc
substanti
number
immortalis
coloni
respect
number
coloni
gener
transform
fuse
unmodifi
sequenc
howev
substanti
less
expect
coloni
observ
sequenc
modifi
elimin
rb
bind
experi
confirm
modifi
hpv
sequenc
insert
vaccinia
viru
substanti
reduc
capac
cell
transform
consid
level
safeti
associ
use
wyeth
strain
vaccinia
suffici
justifi
vaccin
cervic
cancer
patient
strategi
insert
hpv
sequenc
wyeth
strain
select
basi
nucleotid
sequenc
analysi
site
within
genom
whose
disrupt
unlik
affect
capac
viru
replic
henc
gener
immun
respons
figur
show
site
select
insert
lie
within
region
viru
genom
defin
restrict
enzym
fragment
salif
repres
intergen
region
saliflsr
open
read
frame
orf
provid
recombin
vehicl
insert
hpv
sequenc
vaccinia
genom
plasmid
construct
contain
lkb
fragment
span
symmetr
chosen
insert
site
within
vaccinia
viru
genom
locat
f
fragment
defin
sequenc
ctaccag
therapeut
vaccin
cervic
cancer
e
g
boursnel
et
al
fragment
prepar
directli
vaccinia
dna
pcr
also
contain
guanin
phosphoribosyl
transferas
gpt
gene
control
vaccinia
promot
fl
phage
origin
replic
plasmid
modifi
site
direct
mutagenesi
incorpor
uniqu
snab
site
precis
point
dna
insert
plasmid
figur
obtain
insert
snab
site
cassett
contain
code
sequenc
insert
site
invert
respect
code
sequenc
fusion
fusion
place
control
vaccinia
viru
specif
promot
respect
select
basi
known
oper
earli
well
late
time
viru
infect
report
gene
express
late
vaccinia
viru
infect
cycl
fail
provok
mhc
class
irestrict
ctl
use
twostag
transient
domin
select
procedur
insert
hpv
gene
cassett
wyeth
vaccinia
viru
genom
manner
result
retent
unwant
sequenc
figur
first
stage
recombin
virus
acquir
homolog
recombin
whole
plasmid
select
basi
resist
mycophenol
acid
second
stage
involv
passag
viru
absenc
mycophenol
acid
intern
recombin
homolog
sequenc
within
genom
result
format
either
wild
type
viru
design
vwtl
recombin
viru
contain
desir
hpv
cassett
latter
viru
subsequ
design
tahpv
clone
repeat
plaqu
purif
limit
dilut
characteris
extens
genet
unalysi
pcr
analysi
use
confirm
presenc
hpv
gene
cassett
within
recombin
viru
analysi
shown
figur
pair
primer
chosen
bind
outsid
insid
insert
yield
dna
fragment
precis
size
expect
characteris
gene
insert
direct
nucleotid
sequenc
analysi
purifi
viru
dna
use
pcrbase
cycl
sequenc
procedur
comparison
sequenc
deduc
insert
reveal
chang
experi
carri
confirm
genet
stabil
insert
multipl
passag
recombin
viru
high
low
multipl
infect
follow
nine
serial
passag
cell
individu
plaqu
isol
prepar
test
presenc
hpv
express
cassett
pcr
describ
show
presenc
expect
dna
insert
data
shown
wish
confirm
recombin
viru
capabl
express
expect
gene
product
follow
infect
infect
cell
therefor
analys
western
blot
use
antibodi
specif
protein
figur
show
produc
protein
size
expect
protein
judg
comigr
equival
dro
translat
marker
wherea
protein
produc
control
wyeth
viru
strategi
insert
hpvspecif
inform
wyeth
viru
genom
design
creat
recombin
viru
whose
growth
properti
henc
capac
provok
immun
respons
similar
parent
viru
test
compar
growth
properti
wyeth
viva
mous
model
figur
show
titr
two
virus
detect
mous
lung
similar
day
follow
intranas
infect
although
lower
titr
obtain
day
viru
clear
lung
within
day
infect
data
suggest
insert
hpv
gene
cassett
wyeth
genom
substanti
compromis
viru
growth
comparison
two
virus
intracrani
inocul
howev
indic
recombin
viru
substanti
less
neurovirul
parent
wyeth
strain
figur
b
highest
dose
use
io
pfu
death
occur
wherea
wyeth
inocul
anim
die
differ
virul
reproduc
immunosuppress
nude
mice
infect
two
virus
data
shown
sever
diseas
determin
death
presenc
vaccinia
lesion
weight
loss
much
greater
wyeth
parent
recombin
viru
result
unexpect
compar
neurovirul
wyeth
strain
directli
sibl
viru
tahpv
whose
genet
composit
ident
except
presenc
hpv
express
cassett
viru
design
gener
second
round
recombin
gener
tahpv
figur
experi
indic
also
reduc
neurovirul
properti
intracrani
inocul
respect
wyeth
data
shown
suggest
differ
due
insert
hpv
gene
cassett
rather
reflect
heterogen
origin
wyeth
stock
wish
confirm
infect
mice
tahpv
could
stimul
ctl
respons
express
hpv
antigen
cell
could
recognis
target
cell
express
hpv
antigen
mice
inocul
three
time
intraperiton
tahpv
wyeth
vaccinia
recombin
vaccinia
viru
express
unmodifi
sequenc
spleen
remov
day
final
immunis
spleen
cell
cultur
vitro
presenc
synthet
peptid
correspond
known
epitop
restrict
ctl
mice
day
cultur
result
cell
line
test
abil
kill
target
cell
puls
peptid
cell
line
deriv
tahpv
mice
lyse
histocompat
target
cell
rma
puls
peptid
equival
level
lyse
unpuls
target
cell
cell
puls
restrict
ctl
epitop
influenza
viru
lysi
target
cell
line
deriv
spleen
unimmunis
wyeth
immunis
mice
figur
cultur
addit
week
cell
line
deriv
tahpv
immunis
mice
test
abil
recognis
peptid
puls
target
cell
also
cell
express
follow
infect
recombin
vaccinia
virus
figur
signific
lysi
cell
infect
tahpv
indic
ctl
gener
tahpv
capabl
recognis
wild
type
sequenc
synthesi
process
within
target
cell
lysi
tahpv
infect
target
cell
less
cell
puls
puls
target
probabl
result
reduc
epitop
densiti
cell
surfac
compar
peptidepuls
target
cell
lysi
target
cell
infect
wyeth
strain
vaccinia
viru
addit
ctl
gener
immunis
capabl
lyse
target
cell
infect
tahpv
data
shown
design
construct
recombin
vaccinia
viru
express
hpv
hpv
protein
specif
use
treatment
human
cervic
cancer
parent
viru
construct
base
wellcharacteris
vaccin
strain
vaccinia
viru
extens
histori
use
human
recombin
hpv
sequenc
insert
modifi
increas
safeti
margin
like
associ
use
human
show
recombin
viru
carri
hpv
dna
expect
configur
heterolog
code
sequenc
express
success
protein
product
infect
cell
anim
model
studi
indic
recombin
viru
reduc
neurovirul
properti
compar
parent
wyeth
strain
although
intranas
inocul
recombin
produc
somewhat
lower
titr
parent
viru
vaccin
mice
led
gener
hpvspecif
ctl
number
report
anim
model
human
studi
highlight
ctl
particular
effect
agent
tumour
cell
destruct
although
type
immun
respons
may
also
play
role
studi
also
shown
effect
antitumour
respons
induc
vaccin
even
tumour
cell
poorli
immunogen
goal
work
develop
agent
induc
aggress
antitumour
respons
time
primari
cervic
cancer
diagnosi
help
clear
residu
tumour
cell
remain
convent
therapi
surgeri
radiotherapi
success
stage
help
prevent
delay
diseas
recurr
sinc
recurr
almost
alway
fatal
within
rel
short
time
would
repres
major
clinic
advanc
end
recent
carri
initi
clinic
studi
cervic
cancer
patient
viru
describ
report
result
studi
design
primarili
evalu
safeti
approach
assess
hpv
specif
immun
respons
particular
ctl
activ
report
separ
borysiewicz
et
al
submit
public
